Chemoinformaics analysis of Platelet activating factor
| Molecular Weight | 523.692 | nRot | 25 |
| Heavy Atom Molecular Weight | 469.26 | nRig | 2 |
| Exact Molecular Weight | 523.364 | nRing | 0 |
| Solubility: LogS | -0.015 | nHRing | 0 |
| Solubility: LogP | 2.575 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 89.7708 |
| nHD | 0 | BPOL | 73.8412 |
| QED | 0.066 |
| Synth | 3.803 |
| Natural Product Likeliness | 0.644 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.03 |
| Pgp-sub | 0.85 |
| HIA | 0.64 |
| CACO-2 | -5.36 |
| MDCK | 0.0000275 |
| BBB | 0.002 |
| PPB | 0.908669 |
| VDSS | 0.39 |
| FU | 0.0719549 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.829 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.361 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.674 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.681 |
| CYP3a4-inh | 0.737 |
| CYP3a4-sub | 0.03 |
| CL | 2.664 |
| T12 | 0.855 |
| hERG | 0.363 |
| Ames | 0.342 |
| ROA | 0.595 |
| SkinSen | 0.924 |
| Carcinogencity | 0.267 |
| EI | 0.077 |
| Respiratory | 0.793 |
| NR-Aromatase | 0.535 |
| Antiviral | Yes |
| Prediction | 0.770933 |